Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | April 24, 2017 |
| Target | Akorn |
| Sector | Life Science |
| Buyer(s) | Fresenius Kabi USA |
| Deal Type | Add-on Acquisition |
| Deal Value | 4.3B USD |
| Advisor(s) | J.P. Morgan Securities (Financial) Cravath, Swaine & Moore Polsinelli (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Medical Products |
Fresenius Kabi USA LLC is a health care company that focuses on pharmaceuticals and medical devices used to care for critically and chronically ill patients inside and outside the hospital.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Life Science | 1 of 1 |
| Type: Add-on Acquisition | 1 of 2 |
| State: Illinois | 1 of 1 |
| Country: United States | 2 of 3 |
| Year: 2017 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-08 |
BD Rx business
Wilson, North Carolina, United States BD Rx business is a pharmaceutical manufacturing plant developer of medical products. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-03-31 |
Ivenix
North Andover, Massachusetts, United States Ivenix is a medical technology company with a vision to eliminate infusion-related patient harm. The company was founded to develop innovative solutions that transform infusion delivery. Ivenix designed an infusion system from the ground up to streamline medication delivery and bring infusion technology into the digital age. |
Buy | - |
